Topics

"AbbVie antibody drug conjugate misses mark Phase trial∨derfield=score∨derval=desc" Drugs and Medication Database

13:09 EDT 18th July 2019 | BioPortfolio

Here are the most relevant "AbbVie antibody drug conjugate misses mark Phase trial∨derfield=score∨derval=desc" Drugs and Medications that we have found in our database.

More Information about "AbbVie antibody drug conjugate misses mark Phase trial∨derfield=score∨derval=desc" on BioPortfolio

We have published hundreds of AbbVie antibody drug conjugate misses mark Phase trial∨derfield=score∨derval=desc news stories on BioPortfolio along with dozens of AbbVie antibody drug conjugate misses mark Phase trial∨derfield=score∨derval=desc Clinical Trials and PubMed Articles about AbbVie antibody drug conjugate misses mark Phase trial∨derfield=score∨derval=desc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AbbVie antibody drug conjugate misses mark Phase trial∨derfield=score∨derval=desc Companies in our database. You can also find out about relevant AbbVie antibody drug conjugate misses mark Phase trial∨derfield=score∨derval=desc Drugs and Medications on this site too.

Showing "AbbVie antibody drug conjugate misses mark Phase trial" Drugs and Medications 1–25 of 69

ADA

Adagen [leadiant biosciences, inc.]

ADAGEN (pegademase bovine) Injection

ADL

Adlyxin [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use ADLYXIN safely and effectively. See full prescribing information for ADLYXIN. ADLYXIN (lixisenatide) injection, for subcutaneous use Initial U.S. Approval: 2016

AIM

Aimovig [amgen inc]

These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018

AJO

Ajovy [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY.AJOVY (fremanezumab-vfrm) injection, for subcutaneous useInitial U.S. Approval: 2018

BEN

Benzamycin [valeant pharmaceuticals north america llc]

BenzamycinTopical Gel (erythromycin-benzoyl peroxide gel)

BYE

Byetta [physicians total care, inc.]

These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA (exenatide) Injection Initial U.S. Approval: 2005

CAM

Campath [genzyme corporation]

These highlights do not include all the information needed to use CAMPATH safely and effectively. See full prescribing information for CAMPATH. CAMPATH (alemtuzumab) Injection for intravenous useInitial U.S. Approval: 2001

CAR

Carisoprodol [proficient rx lp]

These highlights do not include all the information needed to use Carisoprodol tablets USP safely and effectively. See full prescribing information for Carisoprodol tablets USP. CARISOPRODOL tablets USP for oral use, CIV. Initial U.S. Approval: 1959

CER

Cerezyme [genzyme corporation]

NA

CET

Cetrotide [emd serono, inc.]

Cetrotide 0.25 mg (cetrorelix acetate for injection)

COA

Coagadex [bio products laboratory limited]

These highlights do not include all the information needed to use COAGADEX safely and effectively. See full prescribing information for COAGADEX. COAGADEX (Coagulation Factor X (Human)) Lyophilized Powder for Solution for Intravenous Injection Initial U.S

CRY

Crysvita [ultragenyx pharmaceutical inc.]

These highlights do not include all the information needed to use CRYSVITA safely and effectively. See full prescribing information for CRYSVITA.     CRYSVITA (burosumab- twza ) injection, for subcutaneous use Initial U.S. Approval: 2018

EMG

Emgality [eli lilly and company]

These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY.EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018

ERY

Erythromycin and benzoyl peroxide [oceanside pharmaceuticals]

Erythromycin-Benzoyl Peroxide Topical Gel

Erythromycin and benzoyl peroxide [sandoz inc.]

Erythromycin and Benzoyl Peroxide Topical Gel, USP Topical gel: erythromycin (3%), benzoyl peroxide (5%)

Erythromycin-benzoyl peroxide [physicians total care, inc.]

NA

Erythromycin-benzoyl peroxide [perrigo new york inc]

Erythromycin-Benzoyl Peroxide Topical Gel

Erythromycin-benzoyl peroxide [perrigo new york inc]

Erythromycin-Benzoyl Peroxide Topical Gel

FAS

Fasenra [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use FASENRA safely and effectively. See full prescribing information for FASENRA.FASENRA (benralizumab) injection, for subcutaneous useInitial U.S. Approval: 2017

GEN

Gentamicin sulfate [preferred pharmaceuticals, inc.]

GENTAMICIN SULFATE ophthalmic solution, USP 0.3% sterile

Gentamicin sulfate [proficient rx lp]

GENTAMICIN SULFATE ophthalmic solution, USP 0.3% sterile

Gentamicin sulfate [direct rx]

gentamicin sulfate

Gentamicin sulfate [aidarex pharmaceuticals llc]

GENTAMICIN SULFATEophthalmic solution, USP 0.3%sterile

GIN

Gingimed [massco dental a division of dunagin pharmaceuticals]

NA

HUM

Humira [abbvie inc.]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial U.S. Approval: 2002



Quick Search